Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy

Centre Hospitalier Universitaire de Saint Etienne11 enrolled

Overview

The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol (RGE) sclerotherapy in a first procedure, then followed by vertebroplasty in a second procedure, to treat aggressive vertebral hemangioma patients in tertiary hospital. Exclusion criteria were age \<18-years old and any association with neurological deficit.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Bone Angioma

Interventions

Collecting data from medical recordsOTHER

Data collected: clinical data (particularly pain), biological data, imaging.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Every patients treated by gelled alcohol sclerotherapy for aggressive angiomas, in the University Hospital of Saint-Etienne. Exclusion Criteria: * Patients no treated by gelled alcohol sclerotherapy.

Outcomes

Primary Outcomes

Number of complications identified in data collection

Time frame: Day 1

Secondary Outcomes

Number of lesion identified in data collection